Coronavirus: Vaccination

Department of Health and Social Care written question – answered on 26th January 2022.

Alert me about debates like this

Photo of Charles Walker Charles Walker Chair, Administration Committee, Chair, Administration Committee

To ask the Secretary of State for Health and Social Care, when he expects the MHRA to license a covid-19 nasal vaccine; and whether approval of nasal vaccines will be fast-tracked in line with injectable covid-19 vaccines; and if he will make a statement.

Photo of Maria Caulfield Maria Caulfield The Parliamentary Under-Secretary for Health and Social Care

Any route to approval of nasal vaccine treatments is subject to the developer seeking regulatory approval from the Medicines and Healthcare products Regulatory Agency (MHRA). The MHRA is therefore unable to provide a timetable for the approval of a COVID-19 nasal vaccine, as information on products not approved for use in the United Kingdom is commercially and market-sensitive. As with all other COVID-19 vaccines, the MHRA will ensure a thorough and expedited assessment of any such medicine’s safety and efficacy before any authorisation.

Does this answer the above question?

Yes1 person thinks so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.